Literature DB >> 16891530

Widely distributed and predominant CTX-M extended-spectrum beta-lactamases in Amsterdam, The Netherlands.

N al Naiemi1, A Bart, M D de Jong, C M Vandenbroucke-Grauls, P J G M Rietra, Y J Debets-Ossenkopp, P C Wever, L Spanjaard, A J Bos, B Duim.   

Abstract

Three hundred sixty Enterobacteriaceae and nonfermenting gram-negative bacilli, isolated during one week in May 2004 at five hospitals in Amsterdam, The Netherlands, were evaluated for the presence of extended-spectrum beta-lactamases (ESBLs). A prevalence of 7.8% was found, in contrast to the 1% observed in 1997. CTX-M ESBLs dominated, and four types were identified in 18 isolates.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16891530      PMCID： PMC1594640          DOI： 10.1128/JCM.01112-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

Review 1.  Antibiotic utilization: is there an effect on antimicrobial resistance?

Authors:  J E Patterson
Journal:  Chest       Date:  2001-02       Impact factor: 9.410

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China.

Authors:  Hui Wang; Swathi Kelkar; Weiyuan Wu; Minjun Chen; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

4.  Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology.

Authors:  Nashwan Al Naiemi; Birgitta Duim; Paul H M Savelkoul; Lodewijk Spanjaard; Evert de Jonge; Aldert Bart; Christina M Vandenbroucke-Grauls; Menno D de Jong
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital.

Authors:  A Pałucha; B Mikiewicz; W Hryniewicz; M Gniadkowski
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

6.  Susceptibility of Enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France.

Authors:  J Sirot; M H Nicolas-Chanoine; H Chardon; J L Avril; C Cattoen; J C Croix; H Dabernat; T Fosse; J C Ghnassia; E Lecaillon; A Marmonier; M Roussel-Delvallez; C J Soussy; A Trevoux; F Vandenesch; C Dib; N Moniot-Ville; Y Rezvani
Journal:  Clin Microbiol Infect       Date:  2002-04       Impact factor: 8.067

7.  MYSTIC program: summary of European data from 1997 to 2000.

Authors:  H Goossens
Journal:  Diagn Microbiol Infect Dis       Date:  2001-12       Impact factor: 2.803

8.  TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent clone.

Authors:  P Dumarche; C De Champs; D Sirot; C Chanal; R Bonnet; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

Review 9.  Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control.

Authors:  Enno Stürenburg; Dietrich Mack
Journal:  J Infect       Date:  2003-11       Impact factor: 6.072

10.  Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study.

Authors:  M T Albertini; C Benoit; L Berardi; Y Berrouane; A Boisivon; P Cahen; C Cattoen; Y Costa; P Darchis; E Delière; D Demontrond; F Eb; F Golliot; G Grise; A Harel; J L Koeck; M P Lepennec; C Malbrunot; M Marcollin; S Maugat; M Nouvellon; B Pangon; S Ricouart; M Roussel-Delvallez; A Vachée; Anne Carbonne; Lawrence Marty; Vincent Jarlier
Journal:  J Hosp Infect       Date:  2002-10       Impact factor: 3.926
View more
  11 in total

1.  Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.

Authors:  Marie-Frédérique Lartigue; Catherine Zinsius; Aline Wenger; Jacques Bille; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

2.  Analysis of bla(CTX-M)-carrying plasmids from Escherichia coli isolates collected in the BfT-GermVet study.

Authors:  Anne-Kathrin Schink; Kristina Kadlec; Stefan Schwarz
Journal:  Appl Environ Microbiol       Date:  2011-06-17       Impact factor: 4.792

3.  Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India.

Authors:  Namrata Kumari; Mukesh Kumar; Amit Katiyar; Abhay Kumar; Pallavi Priya; Bablu Kumar; Nihar Ranjan Biswas; Punit Kaur
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

4.  Molecular epidemiology of extended-spectrum beta-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006.

Authors:  Hong Fang; Ferda Ataker; Göran Hedin; Kathrine Dornbusch
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

5.  Emergency (clonal spread) of methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum (ESBL)--and AmpC beta-lactamase-producing Gram-negative bacteria infections at Pediatric Department, Bosnia and Herzegovina.

Authors:  Selma Uzunović; Branka Bedenić; Ana Budimir; Farah Kamberović; Amir Ibrahimagić; Sabina Delić-Bikić; Sara Sivec; Tomislav Meštrović; Dijana Varda Brkić; Michelle I A Rijnders; Ellen E Stobberingh
Journal:  Wien Klin Wochenschr       Date:  2014-09-06       Impact factor: 1.704

Review 6.  Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria.

Authors:  Wei-Hua Zhao; Zhi-Qing Hu
Journal:  Crit Rev Microbiol       Date:  2012-06-15       Impact factor: 7.624

7.  Factors that affect transfer of the IncI1 β-lactam resistance plasmid pESBL-283 between E. coli strains.

Authors:  Nadine Händel; Sarah Otte; Martijs Jonker; Stanley Brul; Benno H ter Kuile
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

8.  Extended-spectrum beta-lactamases screening agar with AmpC inhibition.

Authors:  N Al Naiemi; J L Murk; P H M Savelkoul; C M J Vandenbroucke-Grauls; Y J Debets-Ossenkopp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-20       Impact factor: 3.267

9.  Detection of Healthcare-Related Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Transmission Events Using Combined Genetic and Phenotypic Epidemiology.

Authors:  Anne F Voor In 't Holt; Agnes A Wattel; Stefan A Boers; Ruud Jansen; John P Hays; Wil H F Goessens; Margreet C Vos
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

10.  Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia.

Authors:  Ahmed Zeynudin; Michael Pritsch; Sören Schubert; Maxim Messerer; Gabriele Liegl; Michael Hoelscher; Tefara Belachew; Andreas Wieser
Journal:  BMC Infect Dis       Date:  2018-10-20       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.